Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
CANO.WS was delisted on the 9th of November, 2023.
20 hedge funds and large institutions have $2.18M invested in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 7 closing their positions.
26% less funds holding
Funds holding: 27 → 20 (-7)
31% less capital invested
Capital invested by funds: $3.18M → $2.18M (-$998K)
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
86% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
+$258K |
| 2 |
Walleye Capital
New York
|
+$2.58K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAC
Cowen and Company
New York
|
-$114K |
| 2 |
JAIC
Josh Arnold Investment Consultant
Edina,
Minnesota
|
-$112K |
| 3 |
GL
Governors Lane
New York
|
-$111K |
| 4 |
ICM
Ionic Capital Management
New York
|
-$72.7K |
| 5 |
BOCH
Blue Owl Capital Holdings
New York
|
-$27.2K |
CANO.WS Hedge Fund Activity: Q1 2023 in Review
20 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) for Q1 2023, worth a combined $2.18M — down 31% from $3.18M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of CANO.WS and 1 opened new positions — a net loss of 6 holders — while 5 trimmed existing stakes and 2 added.
The largest buyer was Barclays, adding an estimated $258K. The largest seller was Cowen and Company, cutting an estimated $114K.
- 20 institutional investors held Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) as of Q1 2023, down from 27 in Q4 2022.
- Funds reported $2.18M of Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 stock for Q1 2023, down 31% quarter-over-quarter.
- 1 fund opened new Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 positions in Q1 2023 and 7 closed out, a net change of -6 holders.
- The largest Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 buyer in Q1 2023 was Barclays, an estimated $258K added.
- The largest Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 seller in Q1 2023 was Cowen and Company, an estimated $114K sold.
Based on aggregated 13F filings for Q1 2023.